Innocan Pharma posts Q2 FY2026 revenue of US$5.25M (CAD 7.3M)
Innocan Pharma reported second quarter fiscal year 2026 revenue of US$5.25M (CAD 7.3M).
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Innocan Pharma reported second quarter fiscal year 2026 revenue of US$5.25M (CAD 7.3M).